The path to significant innovation and change can be long, but if you work on major problems creatively and hard enough, you can have a major impact. Khosla Ventures has been actively investing in a number of areas in biology and medicine over the last decade that are now poised to improve the world in a variety of ways. These include efforts in neurotechnology, fetal-maternal medicine, tissue engineering, whole organism engineering, fundamental approaches to age-related diseases, and AI in healthcare and drug discovery. However, the path to impact can take time, and it is important to get the incentive structures for all parties appropriately aligned along the journey, including right at the start of the journey, but they should also be iterated as time unfolds.
Save the date!
Please join on May 16-17, 2024